Browse Articles

Discover research articles across all indexed journals

Does financial asset allocation term structure affect audit fees? Evidence from China

PLoS ONE Chuan Zhang, Hongdi Nie Jan 17, 2025 DOI: 10.1371/journal.pone.0317671

The financialization of real enterprises presents a dilemma for China’s economic development. This study examines the impact of the financial asset allocation term structure on audit fees using a sample of Chinese A-share listed companies from 2009 to 2019. It also investigates the mediating role of financial risk and the moderating role of independent director characteristics. The results indicate that higher long-term financial assets is associated with higher audit fees, while short-term financial assets show no significant relationship with audit fees. These findings remain robust after several tests. Financial risk mediates the relationship between long-term financial assets and audit fees. Furthermore, among the characteristics of independent directors, the proportion of female independent directors and those with a financial background negatively moderate the relationship between long-term financial assets and audit fees, while independent directors with an overseas background and academic credentials positively moderate this relationship. Additional analysis reveals that firm size and financing constraints exhibit heterogeneity in their effects. This study contributes to the literature by enhancing our understanding of the factors influencing firms’ financial asset allocation and audit fees, and by expanding the literature on the financial risk and characteristics of independent directors.

Lipidic folding pathway of α-Synuclein via a toxic oligomer

Nature Communications Vrinda Sant, Dirk Matthes, Hisham Mazal et al. Jan 17, 2025 DOI: 10.1038/s41467-025-55849-3

Abstract Aggregation intermediates play a pivotal role in the assembly of amyloid fibrils, which are central to the pathogenesis of neurodegenerative diseases. The structures of filamentous intermediates and mature fibrils are now efficiently determined by single-particle cryo-electron microscopy. By contrast, smaller pre-fibrillar α-Synuclein (αS) oligomers, crucial for initiating amyloidogenesis, remain largely uncharacterized. We report an atomic-resolution structural characterization of a toxic pre-fibrillar aggregation intermediate (I1) on pathway to the formation of lipidic fibrils, which incorporate lipid molecules on protofilament surfaces during fibril growth on membranes. Super-resolution microscopy reveals a tetrameric state, providing insights into the early oligomeric assembly. Time resolved nuclear magnetic resonance (NMR) measurements uncover a structural reorganization essential for the transition of I1 to mature lipidic L2 fibrils. The reorganization involves the transformation of anti-parallel β-strands during the pre-fibrillar I1 state into a β-arc characteristic of amyloid fibrils. This structural reconfiguration occurs in a conserved structural kernel shared by a vast number of αS-fibril polymorphs including extracted fibrils from Parkinson’s and Lewy Body Dementia patients. Consistent with reports of anti-parallel β-strands being a defining feature of toxic αS pre-fibrillar intermediates, I1 impacts viability of neuroblasts and disrupts cell membranes, resulting in an increased calcium influx. Our results integrate the occurrence of anti-parallel β-strands as salient features of toxic oligomers with their significant role in the amyloid fibril assembly pathway. These structural insights have implications for the development of therapies and biomarkers.

Home intravenous diuretic administration for heart failure management: A scoping review

PLoS ONE Morgan B. Krauter, Katherine S. McGilton, Stuti S. Patel et al. Jan 17, 2025 DOI: 10.1371/journal.pone.0316851

Background Heart failure (HF) significantly impacts healthcare systems due to high rates of hospital bed utilization and readmission rates. Chronic HF often leads to frequent hospitalizations due to recurrent exacerbations and a decline in patient health status. Intravenous (IV) diuretic administration is essential for treating worsening HF. Emerging strategies include home-based IV diuretic therapy administration; however, limited practical implementation guidance is available. This scoping review aims to summarize the literature on home IV diuretic administration for HF patients, focusing on the interventions’ characteristics, and facilitators and barriers to its implementation. Methods This review followed the scoping review framework proposed by Arksey and O’Malley and PRIMSA-ScR. A comprehensive search was conducted across six databases (CINAHL, the Cochrane Library, EMBASE, MEDLINE, PsychINFO and Scopus) and grey literature to identify English studies from inception to April 13, 2024. Two independent reviewers screened articles and resources for inclusion and data was extracted using a form created by the authors in Covidence. Results The search yielded 2,049 results, with nine studies meeting the inclusion criteria. Studies varied in design, including feasibility, pilot, observational, and pre/post-intervention evaluations. The majority were conducted in European countries, with sample sizes ranging from 12 to 96 patients receiving home IV diuretics for HF. Key implementation challenges include appropriate patient selection, IV cannulation competency of healthcare providers, and multi-disciplinary and multi-agency collaboration. Conclusions Evidence on home IV diuretic administration practices for HF management remains limited. However, this scoping review suggests that commonalities across studies could form the basis for developing standard protocols in outpatient settings. Despite the lack of formal evidence-based guidelines, the findings also suggest that tailored, community-specific approaches and safe infusion guidance documents could enhance the efficacy and scalability of home IV diuretic therapy. Future research should focus on refining these strategies and exploring diuretic escalation methods beyond traditional acute care administration to optimize patient outcomes.

Understanding designers’ switching intention to AI painting tools using the PPM framework

Scientific Reports Yilin Liu, Ping Ji Jan 17, 2025 DOI: 10.1038/s41598-025-85950-y

Dynamic hydrogen-bonding enables high-performance and mechanically robust organic solar cells processed with non-halogenated solvent

Nature Communications Haozhe He, Xiaojun Li, Jingyuan Zhang et al. Jan 17, 2025 DOI: 10.1038/s41467-024-55375-8

Abstract Developing active-layer systems with both high performance and mechanical robustness is a crucial step towards achieving future commercialization of flexible and stretchable organic solar cells (OSCs). Herein, we design and synthesize a series of acceptors BTA-C6, BTA-E3, BTA-E6, and BTA-E9, featuring the side chains of hexyl, and 3, 6, and 9 carbon-chain with ethyl ester end groups respectively. Benefiting from suitable phase separation and vertical phase distribution, the PM6:BTA-E3-based OSCs processed by o-xylene exhibit lower energy loss and improved charge transport characteristic and achieve a power conversion efficiency of 19.92% (certified 19.57%), which stands as the highest recorded value in binary OSCs processed by green solvents. Moreover, due to the additional hydrogen-bonding provided by ethyl ester side chain, the PM6:BTA-E3-based active-layer systems achieve enhanced stretchability and thermal stability. Our work reveals the significance of dynamic hydrogen-bonding in improving the photovoltaic performance, mechanical robustness, and morphological stability of OSCs.

Safety and effectiveness of an herbal decoction (modified Saengmaeksan) in hypertensive patients: Protocol for a real-world prospective observational study

PLoS ONE Nahyun Cho, Hobin Moon, Kyung-Min Shin et al. Jan 17, 2025 DOI: 10.1371/journal.pone.0316276

Objective Hypertension, a common chronic disease, often leads to serious complications. While conventional management relies on antihypertensive drugs, which can cause side effects and adherence issues, alternative treatments like herbal medicine are gaining attention. This study examines the efficacy and safety of modified Saengmaeksan, an East Asian herbal remedy, in treating hypertension. Methods This single-arm, prospective, observational study will be conducted at Kyunghee Bichedam Korean Medicine Clinic from October 23, 2023 to August 30, 2024, enrolling 30 hypertensive patients. Over 12 weeks, participants will undergo 4 visits, receiving modified Saengmaeksan twice daily for 8 weeks, with a subsequent 4-week follow-up. Primary outcome is the change in systolic blood pressure from the baseline to week 8. Secondary outcomes include diastolic blood pressure changes, radial artery tonometry, and quality of life evaluations. Safety assessments will include monitoring hematologic parameters and adverse events. Data will be analyzed using an ANCOVA model for adjusting confounders. Discussion Modified Saengmaeksan has shown potential for lowering blood pressure in clinical settings, supported by animal and cell studies. However, human studies are scarce. This research will employ radial artery tonometry to analyze blood pressure comprehensively, exploring Saengmaeksan’s hemodynamic effects. The study’s goal is to support the approval of modified Saengmaeksan as a hypertension treatment by the South Korean Food and Drug Administration and to promote the industrialization of traditional herbal medicine in managing hypertension. The findings will provide essential data for future clinical research, aiding in feasibility assessments and sample size determinations for randomized controlled trials.

Exploring the mechanisms influencing psychological adaptation in athletes in high-risk sports: a moderated mediation model

Scientific Reports Guohua Quan, Hui Xiao, Yanlan Chen Jan 17, 2025 DOI: 10.1038/s41598-025-86432-x

Insights into excitonic behavior in single-atom covalent organic frameworks for efficient photo-Fenton-like pollutant degradation

Nature Communications Chao Zhu, Mingzheng Yang, Bo Jiang et al. Jan 17, 2025 DOI: 10.1038/s41467-025-56103-6

Retraction: An Indole Alkaloid from a Tribal Folklore Inhibits Immediate Early Event in HSV-2 Infected Cells with Therapeutic Efficacy in Vaginally Infected Mice

PLoS ONE Jan 17, 2025 DOI: 10.1371/journal.pone.0318042

Evolutionary game and simulation analysis of tripartite subjects in public health emergencies under government reward and punishment mechanisms

Scientific Reports Dandan Gao, Wei Guo Jan 17, 2025 DOI: 10.1038/s41598-024-80733-3

Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost

Nature Communications Bo Zhang, Youyi Fong, Lauren Dang et al. Jan 17, 2025 DOI: 10.1038/s41467-025-55931-w

Abstract Neutralizing antibody titer has been a surrogate endpoint for guiding COVID-19 vaccine approval and use, although the pandemic’s evolution and the introduction of variant-adapted vaccine boosters raise questions as to this surrogate’s contemporary performance. For 985 recipients of an mRNA second bivalent or monovalent booster containing various Spike inserts [Prototype (Ancestral), Beta, Delta, and/or Omicron BA.1 or BA.4/5] in the COVAIL trial (NCT05289037), titers against 5 strains were assessed as correlates of risk of symptomatic COVID-19 (“COVID-19”) and as correlates of relative (Pfizer-BioNTech Omicron vs. Prototype) booster protection against COVID-19 over 6 months of follow-up during the BA.2-BA.5 Omicron-dominant period. Consistently across the Moderna and Pfizer-BioNTech vaccine platforms and across all variant Spike inserts assessed, both peak and exposure-proximal (“predicted-at-exposure”) titers correlated with lower Omicron COVID-19 risk in individuals previously infected with SARS-CoV-2, albeit significantly less so in naïve individuals [e.g., exposure-proximal hazard ratio per 10-fold increase in BA.1 titer 0.74 (95% CI 0.59, 0.94) for naïve vs. 0.41 (95% CI 0.23, 0.64) for non-naïve; interaction p = 0.013]. Neutralizing antibody titer was a strong inverse correlate of Omicron COVID-19 in non-naïve individuals and a weaker correlate in naïve individuals, posing questions about how prior infection alters the neutralization correlate.

Convolutional neural network (CNN) configuration using a learning automaton model for neonatal brain image segmentation

PLoS ONE Iran Sarafraz, Hamed Agahi, Azar Mahmoodzadeh Jan 17, 2025 DOI: 10.1371/journal.pone.0315538

CNN is considered an efficient tool in brain image segmentation. However, neonatal brain images require specific methods due to their nature and structural differences from adult brain images. Hence, it is necessary to determine the optimal structure and parameters for these models to achieve the desired results. In this article, an adaptive method for CNN automatic configuration for neonatal brain image segmentation is presented based on the encoder-decoder structure, in which the hyperparameters of this network, i.e., size, length, and width of the filter in each layer along with the type of pooling functions with a reinforcement learning approach and an LA model are determined. These LA models determine the optimal configuration for the CNN model by using DICE and ASD segmentation quality evaluation criteria, so that the segmentation quality can be maximized based on the goal criteria. The effectiveness of the proposed method has been evaluated using a database of infant MRI images and the results have been compared with previous methods. The results show that by using the proposed method, it is possible to segment NBI with higher quality and accuracy.

Prognostic value of adjuvant chemotherapy for hormone receptor-negative T1a and T1bN0M0 breast cancer patients

Scientific Reports Yaxiong Liu, Honghui Li, Jinsong Li et al. Jan 17, 2025 DOI: 10.1038/s41598-025-85434-z

Tracking solid electrolyte interphase dynamics using operando fibre-optic infra-red spectroscopy and multivariate curve regression

Nature Communications Cédric Leau, Yu Wang, Charlotte Gervillié-Mouravieff et al. Jan 17, 2025 DOI: 10.1038/s41467-024-55339-y

Investigation of the trends and associated factors of ovarian cancer in Indonesia: A systematic analysis of the Global Burden of Disease study 1990–2021

PLoS ONE Brahmana Askandar Tjokroprawiro, Khoirunnisa Novitasari, Renata Alya Ulhaq et al. Jan 17, 2025 DOI: 10.1371/journal.pone.0313418

Introduction Ovarian cancer is one of the most lethal gynecological cancers. Despite diagnosis and treatment advances, survival rates have not increased over the past 32 years. This study estimated and reported the global burden of ovarian cancer during the past 32 years to inform preventative and control strategies. Methods We examined ovarian cancer incidence, mortality, and disability-adjusted life years (DALYs) using age-standardized rates from the Global Burden of Disease, Injuries, and Risk Factors Study 2021. high body mass index and occupational asbestos exposure were linked with death and DALYs. Data are presented as averages with 95% uncertainty intervals (UIs). Results Indonesia had 13 250 (8 574–21 565) ovarian cancer cases in 2021, with 5 296 (3 520–8958) deaths and 186 917 (121 866–309 820) DALYs. The burden increased by 233.53% for new cases, 221.95% for mortalities, and 206.65% for DALYs. The age-standardized rate also increased from 1990 to 2021. Ovarian cancer burden increased with age but declined in the 50+ year age group. According to the sociodemographic index, the gross domestic product per capita and number of obstetricians and oncologic gynecologists in provinces showed different trends. Conclusions Indonesian ovarian cancer rates are rising despite gynecologic oncologists in 24 of 34 provinces. These findings will help policymakers and healthcare providers identify ovarian cancer prevention and control gaps.

Association of TyG index with mortality at 28 days in sepsis patients in intensive care from MIMIC IV database

Scientific Reports Heping Xu, Jinyuan Xie, Yan Xia et al. Jan 17, 2025 DOI: 10.1038/s41598-025-86746-w

Engineering a membrane protein chaperone to ameliorate the proteotoxicity of mutant huntingtin

Nature Communications Jeonghyun Oh, Christy Catherine, Eun Seon Kim et al. Jan 17, 2025 DOI: 10.1038/s41467-025-56030-6

Abstract Toxic protein aggregates are associated with various neurodegenerative diseases, including Huntington’s disease (HD). Since no current treatment delays the progression of HD, we develop a mechanistic approach to prevent mutant huntingtin (mHttex1) aggregation. Here, we engineer the ATP-independent cytosolic chaperone PEX19, which targets peroxisomal membrane proteins to peroxisomes, to remove mHttex1 aggregates. Using yeast toxicity-based screening with a random mutant library, we identify two yeast PEX19 variants and engineer equivalent mutations into human PEX19 ( hs PEX19). These variants effectively delay mHttex1 aggregation in vitro and in cellular HD models. The mutated hydrophobic residue in the α4 helix of hs PEX19 variants binds to the N17 domain of mHttex1, thereby inhibiting the initial aggregation process. Overexpression of the hs PEX19-FV variant rescues HD-associated phenotypes in primary striatal neurons and in Drosophila . Overall, our data reveal that engineering ATP-independent membrane protein chaperones is a promising therapeutic approach for rational targeting of mHttex1 aggregation in HD.

MRI noise and auditory health: Can one hundred scans be linked to hearing loss? The case of the Courtois NeuroMod project

PLoS ONE Eddy Fortier, Pierre Bellec, Julie A. Boyle et al. Jan 17, 2025 DOI: 10.1371/journal.pone.0309513

Magnetic resonance imaging (MRI) is one of the most commonly used tools in neuroscience. However, it implies exposure to high noise levels. Exposure to noise can lead to temporary or permanent hearing loss, especially when the exposure is long and/or repeated. Little is known about the hearing risks for people undergoing several MRI examinations, especially in the context of longitudinal studies. The goal of this study was to assess the potential impact of repeated exposure to MRI noise on hearing in research participants undergoing dozens of MRI scans. This investigation was made possible thanks to an unprecedented intensive MRI research data collection effort (the Courtois NeuroMod project) where participants have been scanned weekly (up to twice a week), with the use of hearing protection, since 2018. Their hearing was tested periodically, over a period of 1.5 years. First, baseline pure-tone thresholds and distortion product otoacoustic emission (DPOAE) amplitudes were acquired before the beginning of this study. Hearing tests were then scheduled immediately before/immediately after a scan and with a delay of two to seven days after a scan. Pure-tone thresholds and DPOAE amplitudes showed no scanner noise impact right after the scan session when compared to the values acquired right before the scan session. Pure-tone thresholds and DPOAE amplitudes acquired in the delayed condition and compared to the baseline showed similar results. These results suggest an absence of impact from MRI noise exposure. Overall, our results show that an intensive longitudinal MRI study like the Courtois NeuroMod project likely does not cause hearing damage to participants when they properly utilize adequate hearing protection.

Improved feature reduction framework for sign language recognition using autoencoders and adaptive Grey Wolf Optimization

Scientific Reports Rajeev Goel, Sandhya Bansal, Kavita Gupta Jan 17, 2025 DOI: 10.1038/s41598-024-82785-x

MethylBERT enables read-level DNA methylation pattern identification and tumour deconvolution using a Transformer-based model

Nature Communications Yunhee Jeong, Clarissa Gerhäuser, Guido Sauter et al. Jan 17, 2025 DOI: 10.1038/s41467-025-55920-z

Abstract DNA methylation (DNAm) is a key epigenetic mark that shows profound alterations in cancer. Read-level methylomes enable more in-depth analyses, due to their broad genomic coverage and preservation of rare cell-type signals, compared to summarized data such as 450K/EPIC microarrays. Here, we propose MethylBERT, a Transformer-based model for read-level methylation pattern classification. MethylBERT identifies tumour-derived sequence reads based on their methylation patterns and local genomic sequence, and estimates tumour cell fractions within bulk samples. In our evaluation, MethylBERT outperforms existing deconvolution methods and demonstrates high accuracy regardless of methylation pattern complexity, read length and read coverage. Moreover, we show its applicability to cell-type deconvolution as well as non-invasive early cancer diagnostics using liquid biopsy samples. MethylBERT represents a significant advancement in read-level methylome analysis and enables accurate tumour purity estimation. The broad applicability of MethylBERT will enhance studies on both tumour and non-cancerous bulk methylomes.